Escaping cell death: survival proteins in cancer.
暂无分享,去创建一个
[1] I. Konishi,et al. Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. , 1998, Cancer detection and prevention.
[2] X. Ding,et al. Overexpression of the heat shock protein 70 enhances the TCR/CD3- and Fas/Apo-1/CD95-mediated apoptotic cell death in Jurkat T cells. , 1997, Journal of immunology.
[3] F. Mostofi,et al. Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer. , 1996, The Journal of urology.
[4] P. Lipponen,et al. Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. , 1995, British Journal of Cancer.
[5] R. Morimoto,et al. Identification of a regulatory motif in Hsp70 that affects ATPase activity, substrate binding and interaction with HDJ‐1. , 1995, The EMBO journal.
[6] N. Marceau,et al. Synthesis and degradation of heat shock proteins during development and decay of thermotolerance. , 1982, Cancer research.
[7] F. Gago,et al. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. , 1997, Cancer detection and prevention.
[8] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[9] Xiaodong Wang,et al. Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.
[10] M. Jäättelä,et al. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. , 1992, The EMBO journal.
[11] D. Andrews,et al. Bcl‐2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. , 1996, The EMBO journal.
[12] M. Tötsch,et al. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. , 1995, British Journal of Cancer.
[13] J Diebold,et al. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA). , 1996, Blood.
[14] T. McDonnell,et al. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. , 1996, Leukemia.
[15] A. Harris,et al. bcl-2 protein in non-small-cell lung carcinoma. , 1993, The New England journal of medicine.
[16] L. Gordon,et al. BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study. , 1998, Blood.
[17] D. Mckay. Structure and mechanism of 70-kDa heat-shock-related proteins. , 1993, Advances in protein chemistry.
[18] J. Warwick,et al. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. , 1996, Cancer research.
[19] M. Jäättelä,et al. A20 zinc finger protein inhibits TNF and IL-1 signaling. , 1996, Journal of immunology.
[20] Bernd Bukau,et al. The Hsp70 and Hsp60 Chaperone Machines , 1998, Cell.
[21] A. Arrigo. Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. , 1998, Biological chemistry.
[22] S. Fesik,et al. Bcl‐xL regulates apoptosis by heterodimerization‐dependent and ‐independent mechanisms , 1999, The EMBO journal.
[23] Mike Rothe,et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins , 1995, Cell.
[24] D. Altieri,et al. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. , 1998, Cancer research.
[25] J. Landry,et al. Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells , 1989, The Journal of cell biology.
[26] D. Altieri,et al. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma , 1998, The Lancet.
[27] D. Goeddel,et al. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.
[28] Z. Ao,et al. IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival , 1998 .
[29] M. Jäättelä,et al. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type , 1997, Journal of virology.
[30] T G Cotter,et al. Heat shock proteins increase resistance to apoptosis. , 1996, Experimental cell research.
[31] K. Hioki,et al. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. , 1999, Oncology reports.
[32] W. Fiers,et al. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. , 1993, Oncogene.
[33] B. Chauffert,et al. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. , 1997, Cancer research.
[34] D. Marx,et al. Differential Expression of Apoptosis-Associated Genes bax and bcl-2 in Ovarian Cancer. , 1997, Methods in molecular medicine.
[35] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.
[36] F. Hamdy,et al. bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer. , 1996, British Journal of Cancer.
[37] John C Reed,et al. Bcl-2 family proteins , 1998, Oncogene.
[38] P. Cagle,et al. Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases. , 1997, Human pathology.
[39] A. Strasser,et al. The anti‐apoptosis function of Bcl‐2 can be genetically separated from its inhibitory effect on cell cycle entry , 1997, The EMBO journal.
[40] Y. Soini,et al. The extent of apoptosis is inversely associated with bcl‐2 expression in premalignant and malignant breast lesions , 1997, Histopathology.
[41] D. Green,et al. Apoptosis and cancer. , 1994, Important advances in oncology.
[42] R. King,et al. Heat-shock protein 27 (HSP27) and its role in female reproductive organs. , 1997, European journal of gynaecological oncology.
[43] S. Korsmeyer,et al. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.
[44] J. Lee,et al. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] J. D. Robertson,et al. Bcl-xL overexpression restricts heat-induced apoptosis and influences hsp70, bcl-2, and Bax protein levels in FL5.12 cells. , 1997, Biochemical and biophysical research communications.
[46] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[47] I. Ellis,et al. Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy , 1994, International journal of cancer.
[48] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[49] U. Veronesi,et al. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. , 1994, Journal of the National Cancer Institute.
[50] M. Malim,et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] G. Sirugo,et al. Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene Targeting* , 1998, The Journal of Biological Chemistry.
[52] S. Love,et al. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. , 1994, British Journal of Cancer.
[53] F. Gago,et al. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy , 1998, International journal of cancer.
[54] T. Ishida,et al. Overexpression of resistance‐related proteins (metallothioneins, glutathione‐S‐transferase π, heat shock protein 27, and lung resistance‐related protein) in osteosarcoma , 1997, Cancer.
[55] M. Jäättelä. Over‐expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells , 1995, International journal of cancer.
[56] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[57] John Calvin Reed. Promise and problems of Bcl-2 antisense therapy. , 1997, Journal of the National Cancer Institute.
[58] D C Linch,et al. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. , 1996, Blood.
[59] C. Borner,et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c , 1998, Nature.
[60] C. Potten,et al. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. , 1996, British Journal of Cancer.
[61] F. Trautinger,et al. Overexpression of the small heat shock protein, hsp27, confers resistance to hyperthermia, but not to oxidative stress and UV-induced cell death, in a stably transfected squamous cell carcinoma cell line. , 1997, Journal of photochemistry and photobiology. B, Biology.
[62] H. Kolb,et al. Heat shock protein hsp70 overexpression confers resistance against nitric oxide , 1996, FEBS letters.
[63] O. Olopade,et al. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. , 1997, The cancer journal from Scientific American.
[64] John Calvin Reed,et al. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. , 1992, Cancer research.
[65] John Calvin Reed,et al. An Evolutionarily Conserved Family of Hsp70/Hsc70 Molecular Chaperone Regulators* , 1999, The Journal of Biological Chemistry.
[66] S. Hilsenbeck,et al. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. , 1997, Invasion & metastasis.
[67] M. Campbell,et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.
[68] Andy J. Minn,et al. Bcl-xL forms an ion channel in synthetic lipid membranes , 1997, Nature.
[69] M. Birnbaum,et al. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs , 1994, Journal of virology.
[70] S. Tura,et al. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate , 1997, Leukemia.
[71] G. Evan,et al. A matter of life and cell death. , 1998, Science.
[72] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[73] Yuanming Hu,et al. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[74] H. Joensuu,et al. Bcl-2 protein expression and long-term survival in breast cancer. , 1994, The American journal of pathology.
[75] John Calvin Reed,et al. The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.
[76] G. Brittinger,et al. In Acute Myeloid Leukemia only the Coexpression of at Least Two Proteins Including P-Glycoprotein, the Multidrug Resistance-Related Protein MRP, bcl-2, Mutant p53 and Heat-Shock Protein 27 is Predictive for the Response to Induction Chemotherapy , 1998 .
[77] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[78] L. Bourget,et al. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis , 1997, Molecular and cellular biology.
[79] M. Rottenberg,et al. Bcl‐2, Bax and p53 expression in B‐CLL in relation to in vitro survival and clinical progression , 1996, International journal of cancer.
[80] S. Korsmeyer,et al. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.
[81] K. Riabowol,et al. Heat shock is lethal to fibroblasts microinjected with antibodies against hsp70. , 1988, Science.
[82] Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. , 1991 .
[83] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[84] A. Harris,et al. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. , 1994, British Journal of Cancer.
[85] E. Solary,et al. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. , 1998, Cancer research.
[86] D. Cunningham,et al. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma , 1997, The Lancet.
[87] H. Auer,et al. HSP70 overexpression mediates the escape of a doxorubicin-induced G2 cell cycle arrest. , 1996, Biochemical and biophysical research communications.
[88] D. Green,et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.
[89] S. Hilsenbeck,et al. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[90] L. Weber,et al. Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. , 1996, Cancer research.
[91] W. Park,et al. The role of inducible 70-kDa heat shock protein in cell cycle control, differentiation, and apoptotic cell death of the human myeloid leukemic HL-60 cells. , 1998, Cellular immunology.
[92] G. Wilson,et al. Bcl-2 expression in malignant melanoma and its prognostic significance. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[93] Huiling He,et al. Maintenance of Calcium Homeostasis in the Endoplasmic Reticulum by Bcl-2 , 1997, The Journal of cell biology.
[94] M. Jäättelä,et al. Hsp70 exerts its anti‐apoptotic function downstream of caspase‐3‐like proteases , 1998, The EMBO journal.
[95] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.
[96] B. Lloveras,et al. Bcl‐2 expression is associated with lymph node metastasis in human ductal breast carcinoma , 1995, International journal of cancer.
[97] R. Herrmann,et al. Five putative drug resistance parameters (MDR1/P‐glycoprotein, MDR‐associated protein, glutathione‐S‐transferase, bcl‐2 and topoisomerase IIα) in 57 newly diagnosed acute myeloid leukaemias , 1997 .
[98] H. Friess,et al. bax, but notbcl-2, influences the prognosis of human pancreatic cancer , 1998, Gut.
[99] S. Gebhard,et al. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas , 1993, Histopathology.
[100] R. Ralhan,et al. Differential expression of Mr 70,000 heat shock protein in normal, premalignant, and malignant human uterine cervix. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[101] S. Chaufour,et al. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. , 1999, Experimental cell research.
[102] G. Li,et al. Thermal response of rat fibroblasts stably transfected with the human 70-kDa heat shock protein-encoding gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[103] C. Osborne,et al. Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study). , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[104] T. Chard,et al. Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer. , 1998, British Journal of Cancer.
[105] Y. Akao,et al. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. , 1994, Cancer research.
[106] G. Evan,et al. Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells , 1991, Journal of virology.
[107] D. Altieri,et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. , 1998, Cancer research.
[108] G. Kroemer,et al. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins , 1998, Oncogene.
[109] D. Mason,et al. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. , 1990, The American journal of pathology.
[110] T. Ito,et al. Expression of heat shock proteins in squamous cell carcinoma of the tongue: an immunohistochemical study. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[111] Jong-il Kim,et al. T Cell Lymphoma in Transgenic Mice Expressing the HumanHsp70Gene , 1996 .
[112] J C Reed,et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. , 1998, Cancer research.
[113] J. Magaud,et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. , 1993, Blood.
[114] D R Ciocca,et al. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. , 1993, Journal of the National Cancer Institute.
[115] R. Ralhan,et al. Differential expression of 70–kDa heat shock‐protein in human oral tumorigenesis , 1995, International journal of cancer.
[116] S. Korsmeyer,et al. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. , 1998, Blood.
[117] J C Reed,et al. Channel formation by antiapoptotic protein Bcl-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[118] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.
[119] A. Giatromanolaki,et al. Bcl-2 and p53 expression in stage I endometrial carcinoma. , 1998, Anticancer research.
[120] S. Lindquist,et al. The heat-shock proteins. , 1988, Annual review of genetics.
[121] C. Y. Wang,et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.
[122] K. Trieb,et al. Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy. , 1998, Human pathology.
[123] M. Quaia,et al. Expression of heat shock protein 72 in renal cell carcinoma: possible role and prognostic implications in cancer patients. , 1997, European journal of cancer.
[124] C. Angeletti,et al. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. , 1995, British Journal of Cancer.
[125] J C Reed,et al. IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.
[126] G. Núñez,et al. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. , 1993, The American journal of pathology.
[127] T. Chittenden,et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[128] P. Mehlen,et al. Human hsp27, Drosophila hsp27 and human alphaB‐crystallin expression‐mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha‐induced cell death. , 1996, The EMBO journal.
[129] R. Issels,et al. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. , 1997, Journal of immunology.
[130] H. Kampinga,et al. In Vivo Chaperone Activity of Heat Shock Protein 70 and Thermotolerance , 1999, Molecular and Cellular Biology.
[131] R. Kuick,et al. Hsp27 expression in neuroblastoma: correlation with disease stage. , 1994, Journal of the National Cancer Institute.
[132] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.
[133] T. Furukawa,et al. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[134] D. Hicks,et al. BCL-2 expression in human colorectal adenomas and carcinomas. , 1994, Oncogene.
[135] V. Dixit,et al. Boo, a novel negative regulator of cell death, interacts with Apaf‐1 , 1999, The EMBO journal.
[136] M. V. Heiden,et al. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. , 1999, Molecular cell.
[137] M. Simon,et al. Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. , 1995, The Journal of clinical investigation.
[138] I. Bodrogi,et al. Expression of bcl‐2 in testicular carcinoma , 1998, Cancer.
[139] M. Akami,et al. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. , 1995, Journal of pediatric surgery.
[140] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[141] S. Chen,et al. Diva, a Bcl-2 Homologue that Binds Directly to Apaf-1 and Induces BH3-independent Cell Death* , 1998, The Journal of Biological Chemistry.
[142] D. Altieri,et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.
[143] G. Baretton,et al. Apoptosis and immunohistochemical bcl‐2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance , 1996, Cancer.
[144] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[145] Fengzhi Li,et al. Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.
[146] V. Dixit,et al. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. , 1995, Oncogene.
[147] S. Nagata,et al. Effect of bcl-2 on Fas antigen-mediated cell death. , 1993, Journal of immunology.
[148] V. Dixit,et al. Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex* , 1998, The Journal of Biological Chemistry.
[149] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[150] John Calvin Reed,et al. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. , 1998, Blood.
[151] R. J. Clem,et al. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif , 1993, Journal of virology.
[152] J. Diebold,et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. , 1998, The American journal of pathology.
[153] S. Leach,et al. bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[154] R. Johnston,et al. Competitive inhibition of hsp70 gene expression causes thermosensitivity. , 1988, Science.
[155] F. Liu,et al. Potential role of HSP70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer. , 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[156] J. Smyth,et al. Expression of the heat shock protein HSP27 in human ovarian cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[157] K. Franssila,et al. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. , 1995, Cancer research.
[158] E. van Marck,et al. Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix. , 1997, Journal of clinical pathology.
[159] K. Schulze-Osthoff,et al. Small Stress Proteins as Novel Regulators of Apoptosis , 1996, The Journal of Biological Chemistry.
[160] S. Horman,et al. ANTISENSE INHIBITION OF THE 27 kDa HEAT SHOCK PROTEIN PRODUCTION AFFECTS GROWTH RATE AND CYTOSKELETAL ORGANIZATION IN MCF‐7 CELLS , 1996, Cell biology international.
[161] M. Jäättelä,et al. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection , 1993, The Journal of experimental medicine.
[162] H. Moch,et al. Prognostic significance of Bcl-2 in clinically localized prostate cancer. , 1996, The American journal of pathology.
[163] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[164] K. Hirakawa,et al. Predictive Value of Bcl-2 and Bax Protein Expression for Chemotherapeutic Effect in Gastric Cancer , 1998, Oncology.
[165] P Boracchi,et al. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[166] W. McGuire,et al. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. , 1993, Journal of the National Cancer Institute.
[167] P. Rose,et al. Analysis of heat‐shock protein expression in myeloid leukaemia cells by flow cytometry , 1995, British journal of haematology.
[168] A. MacKenzie,et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer , 1998, Oncogene.
[169] P. Athanassiadou,et al. Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[170] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[171] Céline Gélinas,et al. Rel/NF-?B and I?B factors in oncogenesis , 1997 .
[172] D. Chao,et al. BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.
[173] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[174] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[175] J. Jenkins,et al. Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells , 1988, Molecular and cellular biology.
[176] M. Fukui,et al. Distinctive immunohistochemical profiles of small heat shock proteins (Heat shock protein 27 and αB‐crystallin) in human brain tumors , 1996, Cancer.
[177] H. Kim,et al. Modulation of endoplasmic reticulum calcium pump by Bcl-2 , 1998, Oncogene.
[178] W. Wilmanns,et al. Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. , 1996, Leukemia.
[179] A. Strasser,et al. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.